MELI — Mellifera AD Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -15.97% | ||
| Return on Equity | -14.16% | ||
| Operating Margin | -55.73% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | BGNm | n/a | 0.14 | 0.19 | 0.18 | 0.39 | n/a | n/a | 41.86% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Mellifera AD is a Bulgaria-based company engaged in producing and marketing honey-based products. The focus of the Company is the application of organic honey promotion of healthy alternatives. Products such as pure or flavored organic honey, organic honey energy gel or blends of honey with various other superfoods are offered to the customers from Singapore, Hong Kong, Kuwait, Saudi Arabia and the UAE. The Company focuses on food for athletes, functional nutritional supplements and supports organic beekeepers. The Company's flagship product - MelliGEL is an organic energy gel, designed for endurance and concentration during prolonged exercise. The product has the dual use for energy and recovery.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- June 9th, 2022
- Public Since
- January 17th, 2023
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Bulgarian Stock Exchange
- Shares in Issue
- 885,282
- Address
- ul. Ilarion Dragostinov 46, SOFIA
- Web
- https://www.melligel.com/
- Phone
- Auditors
- AFA OOD
Similar to MELI
Agria Holding AD
Bulgarian Stock Exchange
Bulgarska Zahar AD
Bulgarian Stock Exchange
Bulgartabac Holding AD
Bulgarian Stock Exchange
Dupnitsa Tabac AD
Bulgarian Stock Exchange
Gotse Delchev Tabac AD
Bulgarian Stock Exchange
FAQ
As of Today at 22:00 UTC, shares in Mellifera AD are trading at BGN4.50. This share price information is delayed by 15 minutes.
Shares in Mellifera AD last closed at BGN4.50 and the price had moved by +2.27% over the past 365 days. In terms of relative price strength the Mellifera AD share price has underperformed the FTSE Global All Cap Index by -0.29% over the past year.
There is no consensus recommendation for this security.
Find out moreMellifera AD does not currently pay a dividend.
Mellifera AD does not currently pay a dividend.
Mellifera AD does not currently pay a dividend.
To buy shares in Mellifera AD you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of BGN4.50, shares in Mellifera AD had a market capitalisation of .
Here are the trading details for Mellifera AD:
- Country of listing: Bulgaria
- Exchange: BLG
- Ticker Symbol: MELI
Based on an overall assessment of its quality, value and momentum Mellifera AD is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mellifera AD. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +2.61%.
As of the last closing price of BGN4.50, shares in Mellifera AD were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Mellifera AD PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at BGN4.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Mellifera AD's directors